Mumbai-based Jesons Industries, has refiled its draft red herring prospectus with the market regulator Securities and ...
Agios Pharma submitted a sNDA to the FDA after two Phase III trials studying PYRUKYND (mitapivat) in thalassemia met their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback